|Pfizer Inc -- Germany Stock|| |
EUR 30.5 0.31 1.01%
Group President - Vaccines, Oncology and Consumer Healthcare Business
Mr. Albert Bourla is Group President Pfizer Innovative Health of the company. He was Group President, Global Innovative Pharma Business from February 2016 until June 2016 and Group President, Vaccines, Oncology and Consumer Healthcare since January 2014. President and General Manager of Established Products Business Unit from December 2010 until December 2013. Area President Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 until November 2010. Area President Europe, Africa and Middle East of Pfizer Animal Health from 2005 until 2009.
Age: 54 President Since 2016
Albert Bourla Latest Insider Activity
The company has return on total asset (ROA)
of 5.27 %
which means that it generated profit of $5.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 13.68 %
meaning that it generated $13.68 on every $100 dollars invested by stockholders.
The company has accumulated 43.87 B in total debt with debt to equity ratio (D/E) of 74.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Pfizer Inc has Current Ratio of 1.31 which is within standard range for the sector.
Pfizer Inc (PFE) is traded on Frankfurt Stock Exchange in Germany. and employs 28 people.